Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade.
Lipson, Evan J
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade. [electronic resource] - Journal for immunotherapy of cancer 2017 - 23 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
2051-1426
10.1186/s40425-017-0228-3 doi
Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
B7-H1 Antigen--antagonists & inhibitors
Carcinoma, Basal Cell--drug therapy
Female
Gene Expression Regulation, Neoplastic--drug effects
Hedgehog Proteins--antagonists & inhibitors
Humans
Lymphocytes, Tumor-Infiltrating--drug effects
Male
Middle Aged
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Signal Transduction--drug effects
Tumor Microenvironment--drug effects
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade. [electronic resource] - Journal for immunotherapy of cancer 2017 - 23 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
2051-1426
10.1186/s40425-017-0228-3 doi
Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized--administration & dosage
B7-H1 Antigen--antagonists & inhibitors
Carcinoma, Basal Cell--drug therapy
Female
Gene Expression Regulation, Neoplastic--drug effects
Hedgehog Proteins--antagonists & inhibitors
Humans
Lymphocytes, Tumor-Infiltrating--drug effects
Male
Middle Aged
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Signal Transduction--drug effects
Tumor Microenvironment--drug effects